KMS Chongqing Institute of Green and Intelligent Technology, CAS
Engineered Cell Membrane-Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune Modulation | |
Ma, Yilei1,2,3; Yi, Jia1,2; Ruan, Jing1,2; Ma, Jiahui1,2; Yang, Qinsi4; Zhang, Kun5; Zhang, Maolan6; Zeng, Guoming6; Jin, Libo1,2,3; Huang, Xiaobei7 | |
2024-05-02 | |
摘要 | Gliomas, the most prevalent primary brain tumors, pose considerable challenges due to their heterogeneity, intricate tumor microenvironment (TME), and blood-brain barrier (BBB), which restrict the effectiveness of traditional treatments like surgery and chemotherapy. This review provides an overview of engineered cell membrane technologies in glioma therapy, with a specific emphasis on targeted drug delivery and modulation of the immune microenvironment. This study investigates the progress in engineered cell membranes, encompassing physical, chemical, and genetic alterations, to improve drug delivery across the BBB and effectively target gliomas. The examination focuses on the interaction of engineered cell membrane-coated nanoparticles (ECM-NPs) with the TME in gliomas, emphasizing their potential to modulate glioma cell behavior and TME to enhance therapeutic efficacy. The review further explores the involvement of ECM-NPs in immunomodulation techniques, highlighting their impact on immune reactions. While facing obstacles related to membrane stability and manufacturing scalability, the review outlines forthcoming research directions focused on enhancing membrane performance. This review underscores the promise of ECM-NPs in surpassing conventional therapeutic constraints, proposing novel approaches for efficacious glioma treatment. Engineered cell membrane-coated nanoparticles (ECM-NPs) have enhanced drug delivery across the blood-brain barrier to more effectively target glioma cells. The interaction of these ECM-NPs with the tumor microenvironment (TME) in the glioma and their effect on the immune response are highlighted, showing their potential to modify glioma cell behavior and modulate the TME to improve therapeutic outcomes. image |
关键词 | engineered cell membrane-coated nanoparticles glioma immunomodulation strategies targeted drug delivery tumor microenvironment |
DOI | 10.1002/adhm.202400514 |
发表期刊 | ADVANCED HEALTHCARE MATERIALS |
ISSN | 2192-2640 |
页码 | 17 |
通讯作者 | Li, Jianshu(jianshu_li@scu.edu.cn) ; Yang, Haifeng(yanghaifeng@cqu.edu.cn) ; Wu, Wei(david2015@cqu.edu.cn) ; Sun, Da(sunday@wzu.edu.cn) |
收录类别 | SCI |
WOS记录号 | WOS:001216832900001 |
语种 | 英语 |